Recombinant Human CD157 (C-6His)

Description

EnkiLife provides the Recombinant Human CD157 (C-6His) protein,aslo know as ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,ADP-ribosyl cyclase 2,Bone marrow stromal antigen 1,BST-1,Cyclic ADP-ribose hydrolase 2,cADPr hydrolase 2,CD157, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human ADP-ribosyl Cyclase/Cyclic ADP-ribose Hydrolase 2 is produced by our Mammalian expression system and the target gene encoding Gly29-Lys292 is expressed with a 6His tag at the C-terminus.Accession:Q10588. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:30.8 KDa. Background:The cluster of differentiation (CD) system is a glycosyl phosphatidylinositol anchored membrane protein that belongs to the CD38 family.It is generally used in immunophynotyping. CD157 was discovered in a bone marrow stromal cell line where it facilitates pre-B-cell growth. CD157 is a bifunctional ectoenzyme that exhibits both ADP-ribosyl cyclase and cyclic ADP ribose hydrolase activities followed with CD38. It plays a role in rheumatoid arthritis (RA) due to its enhanced expression in RA-derived bone marrow stromal cell lines. Studies have shown that this protein have a role in predicted to function as a cell surface receptor and an immunoregulatory molecule.